Dual Empagliflozin and Sacubitril/Valsartan Therapy Improves Ex Vivo Cardiac Function in a Rat Model of Heart Failure

<b>Background/Objectives:</b> This study aimed to clarify the cardioprotective effects of combined empagliflozin and sacubitril/valsartan therapy in an experimental rat model of heart failure (HF). The main research question was whether dual treatment provides greater functional and molecular benefi...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Maja Murić, Ivan Srejović, Marko Ravić, Jovana Joksimović Jović, Jasmina Sretenović, Marina Nikolić, Nevena Lazarević, Marijana Andjić, Aleksandar Kočović, Sergey Bolevich, Vladimir Jakovljević, Jovana Novaković
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2026-05-01
Reeks:	Biomedicines
Onderwerpen:	heart failure empagliflozin sacubitril/valsartan ex vivo cardiac function gene expression
Online toegang:	https://www.mdpi.com/2227-9059/14/5/1115
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!